Ensign Peak Advisors’s Nuvalent NUVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.5M Buy
102,312
+48,110
+89% +$4.9M 0.02% 400
2025
Q4
$5.45M Sell
54,202
-10,177
-16% -$1M 0.01% 506
2025
Q3
$5.57M Sell
64,379
-30,461
-32% -$2.41M 0.01% 571
2025
Q2
$7.24M Sell
94,840
-33,576
-26% -$2.46M 0.01% 557
2025
Q1
$9.11M Buy
128,416
+118,944
+1,256% +$9.3M 0.02% 489
2024
Q4
$741K Sell
9,472
-10,000
-51% -$934K ﹤0.01% 1473
2024
Q3
$1.99M Buy
19,472
+10,000
+106% +$829K ﹤0.01% 955
2024
Q2
$719K Hold
9,472
﹤0.01% 1476
2024
Q1
$711K Sell
9,472
-228
-2% -$18.1K ﹤0.01% 1518
2023
Q4
$714K Buy
9,700
+2,300
+31% +$142K ﹤0.01% 1555
2023
Q3
$340K Buy
7,400
+1,700
+30% +$75.5K ﹤0.01% 1670
2023
Q2
$240K Buy
+5,700
New +$215K ﹤0.01% 1733
2022
Q2
Sell
-60,000
Closed -$834K 2190
2022
Q1
$834K Hold
60,000
﹤0.01% 1306
2021
Q4
$1.14M Hold
60,000
﹤0.01% 1205
2021
Q3
$1.35M Buy
+60,000
New +$1.74M ﹤0.01% 1304

Other funds holding NUVL

Ensign Peak Advisors's NUVL Position: Q1 2026 in Review

Ensign Peak Advisors increased its Nuvalent (NUVL) stake by 89% in Q1 2026, buying an estimated $4.9M and bringing the position to 102,312 shares worth $10.5M. The position accounts for 0.02% of the portfolio, ranked #400.

Ensign Peak Advisors first reported a position in NUVL in Q3 2021 and has held it in 15 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Ensign Peak Advisors held 102,312 shares of Nuvalent worth $10.5M as of Q1 2026.
  • Ensign Peak Advisors bought 48,110 Nuvalent shares in Q1 2026, an estimated $4.9M.
  • Nuvalent made up 0.02% of Ensign Peak Advisors's portfolio in Q1 2026, its #400 holding.
  • Ensign Peak Advisors first reported a position in Nuvalent in Q3 2021 and has held it in 15 quarters since.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.